NICOLE BARNES: Open Payments
NPI 1407593510 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 39 payments from 16 companies in 2025. Trend: 2023 $470 · 2024 $623 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $177 |
| PFIZER INC. | 8 | $173 |
| Lilly USA, LLC | 3 | $55 |
| Dexcom, Inc. | 2 | $51 |
| Corcept Therapeutics | 1 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| ABBVIE INC. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
Products named: ELIQUIS, Ozempic, MOUNJARO, Dexcom G6 Transmitter, Korlym, Kerendia, PAXLOVID, Wegovy.
Industry payments across TX — which companies pay providers there.
